Consistent with the latter, USP21 loss did not significantly alter the survival of CAPAN-1 prostate cancer cells, which express a hypomorphic BRCA2 protein lacking its USP21-interacting C-terminal domain (Figs. 3d and 5g). The gene discussed is USP21; the disease is prostate cancer.